Tizanidine
Product Images NDC 67296-1192

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 67296-1192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Tizanidine 67296 1192)

This is a description of a medication package for Tizanidine HCL 4mg with a lot number, expiration date, and information on dosage and storage. The medication is manufactured by Unichem Laboratories in Goa, India and distributed by Redpharm Drug in Minnesota, USA. The NDC number is 67296-1192-1 and there are 15 tablets in the package.*

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

This text describes the improvement in Ashworth score at different stages of a study using a mean dose of 26.8 mg. The Ashworth score measures muscle spasticity in patients. The study had a titration phase (lasting for 3 weeks) and a maintenance phase (lasting for 7 weeks), and the endpoint was determined using the last observation carried forward method.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

This text only contains the name of the company "UNICHEM PHARMACEUTICALS (USA). INC." and does not provide any useful information about it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.